News

We reviewed studies comparing different combinations of flow rates, pressures, and timings used to support breathing in premature babies (less than 37 weeks of pregnancy) after the breathing tube is ...
The airway management devices market is experiencing significant expansion, driven by increasing prevalence of chronic respiratory diseases, rising surgical procedures, and breakthrough innovations ...
The prevalence of respiratory and chronic obstructive pulmonary disease (COPD) are the main factors driving the rise in ...
Teleflex has acquired BIOTRONIK's Vascular Intervention business, enhancing its portfolio and global market presence.
WAYNE, Pa. - Teleflex Incorporated (NYSE:TFX) has completed its acquisition of substantially all of BIOTRONIK SE & Co. KG’s Vascular Intervention business for €760 million, the medical ...
On February 27, 2025, Teleflex announced its entry into a definitive agreement to acquire substantially all of BIOTRONIK’s Vascular Intervention business. Under the terms of the agreement, Teleflex ...
Under the terms of the agreement, Teleflex acquired the Vascular Intervention business for a cash payment of €760 million, less certain adjustments as provided in the purchase agreement ...
On February 27, 2025, Teleflex announced its entry into a definitive agreement to acquire substantially all of BIOTRONIK’s Vascular Intervention business. Under the terms of the agreement ...
WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced ...
July 1, 2025—Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention business of Biotronik. On February 27, 2025, Teleflex announced it ...